Lilly diabetes drug slashes deaths 32 pct in heart-risk patients
Lilly diabetes drug slashes deaths 32 pct in heart-risk patients
(Reuters) - Eli Lilly and Co's new Jardiance pill slashed deaths by 32 percent in a study of 7,000 patients with type 2 diabetes at risk of heart attack and stroke, a finding that researchers said could make it a mainstay diabetes treatment.